Skip to main content
Equibles

Pier Capital, LLC

Position in COGT — Cogent Biosciences, Inc.

CIK 1310051 STAMFORD, CT
Back to COGT Full portfolio

Position in COGT

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$7,312,403
+$3,413,213 QoQ
Shares Held
188,951
+86.5% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 62% Shared 0% None 38%

Common Shares in COGT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Pier Capital, LLC holds $37,295,784 across 8 Biotechnology names. COGT ranks #2 (19.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DRTS
Alpha Tau Medical Ltd.
 691,939 $8,704,592
2 COGT
Cogent Biosciences, Inc.
This page 		188,951 $7,312,403
3 CYTK
Cytokinetics Inc
 70,665 $6,019,951
4 DFTX
Definium Therapeutics, Inc.
 88,598 $4,167,649
5 SPTX
Seaport Therapeutics, Inc.
 169,985 $3,692,074
6 OLMA
Olema Pharmaceuticals, Inc.
 220,699 $2,760,944
7 CAPR
Capricor Therapeutics, Inc.
 111,908 $2,694,744
8 KYMR
Kymera Therapeutics, Inc.
 16,948 $1,943,427

All Filings in COGT

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,312,403 188,951
2026-03-31 $3,899,190 101,304
2025-12-31 $1,643,155 46,260